2014 Fiat 500 Abarth on 2040-cars

Auto blog

Fiat jokes 124 Spider as effective as Viagra

Fiat has released a follow up to its innuendo-laden 500X ad from last year. But rather than a crossover, um, reacting to a certain little blue pill, the company's new 124 Spider is the pill. Now, Road and Track readers might remember seeing something about this video. It originally aired as part of the 124 Spider's debut footage from the 2015 Los Angeles Auto Show. At the time, it wasn't supposed to become a commercial – it was just a riff on a cheeky spot meant to sell CUVs. This new commercial is identical to the original footage shown in LA. Using the same old Italian couple as the previous spot, this new ad features an Italian man run out of his Viagra, and run off to get more. As it turns out, he just didn't need it. That's about all you need to know, really. So check out the ad up top.

2016 Fiat 500X First Drive [w/videos]

Fiat's return to the US market four years ago is already cooling off. Neither the Lilliputian 500 or its larger sibling, the 500L, have caught on with mainstream customers. Both were designed years ago for European roads, which are tight and crowded. That's the antithesis of America's driving ethos. Fiat knows this, and its answer is the 2016 500X. It lays the brand's curvy design over a crossover-style package with available all-wheel-drive. There's more room for cargo to suit our national preference for extra space. The 500X still has Italian charm, but it feels more at home on US roads than other Fiats. Put simply, the 500X isn't a transplant, it's made for American buyers (even if it's assembled in Italy, alongside the Jeep Renegade). We were skeptical that the 500X could turn around Fiat's fortunes, but this cute crossover had a way of winning us over. Maybe it was the bright arancio paint (Italian for "orange") of our test car, the most expressive of the 12 exterior hues. Even in the shadowy indoor setting where our test drive begins, in Culver City, CA, this car stands out. In stark contrast, the black and grey interior is subdued and tasteful. Out test car is a Trekking model, the middle of five trim levels, fitted with the optional 2.4-liter engine. This naturally aspirated four-cylinder is a 'free' upgrade from the standard 1.4-liter turbo, but mandates the addition of a nine-speed automatic transmission for $1,500. Taking off through morning traffic, we head for the Santa Monica Freeway. At the entrance we're pitted against an older Toyota Camry in an on-ramp drag race. We lay on the throttle to put the Tigershark engine's 180 horsepower and 175 pound-feet of torque into full use, and leave the Camry in the dust. As we head north toward Malibu, we can already tell that the 500X feels like a different kind of Fiat, more substantial. It fills the lane. There's an upright driving position, and we feel confident cruising along at 70 miles per hour. Okay, so the 500X can handle an interstate, but what about an open road? We make our way to the Pacific Coast Highway, California's State Route 1, a logical place to test Fiat's claim of being more in step with American buyers. There are stoplights. People wander across the street towards the beach. Cars pass us and we pass them. Subtract the ocean air and surfers, and this road is what a lot of US motorists deal with every day. The 500X is all up for it.

Investors want answers about Marchionne’s final days

The mystery of Sergio Marchionne's surprise death last week continues, with investors now questioning the timeliness of disclosures by the company and family. Bloomberg reports that Italy's market regulator is making a routine check into how Fiat Chrysler handled communications regarding his illness. Fiat Chrysler's stock is down 12 percent in both Italy and on the New York Stock Exchange since the announcement of Marchionne's death. University Hospital Zurich last week issued a statement saying that Marchionne, who died July 25 while recovering from an unspecified should surgery, had been treated for more than a year for a serious illness that it didn't define. Marchionne's family told Reuters the companies hadn't been aware of his health conditions. The Italian business website Lettera 43 reported July 5, and FCA later confirmed, that Marchionne had undergone shoulder surgery in a Swiss hospital. But the company later denied a July 20 report by the website that Fiat Chairman John Elkann planned to meet with company leaders to divide Marchionne's responsibilities. Yet the FCA board indeed met on July 21 and chose Mike Manley, who had formerly overseen the Jeep and Ram brands, to succeed Marchionne as CEO. The company on July 25 published a brief statement acknowledging the former CEO's death. "Unfortunately, what we feared has come to pass. Sergio Marchionne, man and friend, is gone," Elkann said in the statement. Marchionne told no one outside his inner circle — reportedly not even Elkann — that he was seriously ill. His partner, Manuela Battezzato, who works in Fiat's press department, told Bloomberg that Marchionne's family didn't tell the company about his health condition. The famously hard-working CEO, who had quit smoking about a year ago, had also reportedly stopped responding to messages and calls from some advisors since the end of June. People close to him told Bloomberg that Marchionne died from complications following the shoulder surgery, including two cardiac arrests. Image Credit: Ferrari flags hang at half-staff at the Hungarian Grand Prix / Getty Chrysler Fiat Sergio Marchionne